ACUTE LYMPHOCYTIC LEUKEMIA OPTIONS

Drug interactions are now the best obstacle in dealing with HIV/HCV co-infected people. In terms of safety outcomes, tenofovir DF utilised with ledipasvir or velpatasvir may result in a rise in serum creatinine, specially when coupled with a pharmacokinetic booster. [139] Using tenofovir DF ought to be prevented in these cases if the patient’s ba